The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

Background and Aims: It’s reported that bone morphogenetic protein 9 (BMP9) played an important role in lipid and glucose metabolism, but the role of BMP9 in nonalcoholic fatty liver disease (NAFLD) is unclear. Here, we evaluated the therapeutic efficacy of recombined BMP9 in NAFLD mice and investig...

Full description

Bibliographic Details
Main Authors:	Qin-Juan Sun, Ling-Yan Cai, Jie Jian, Ya-Lu Cui, Chen-Kai Huang, Shu-Qing Liu, Jin-Lai Lu, Wei Wang, Xin Zeng, Lan Zhong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Pharmacology
Subjects:	BMP9 NAFLD hepatic steatosis glucose metabolism inflammatory response RNA-seq
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.605967/full

Similar Items

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01)

Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro
by: Abdo Mahli, et al.
Published: (2019-05-01)

Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice
by: Eun-Young Park, et al.
Published: (2015-11-01)

DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease
by: Stella Tommasi, et al.
Published: (2019-08-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
by: Alihan Oral, et al.
Published: (2019-09-01)

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
by: Shan Li, et al.
Published: (2018-06-01)

The role of intestinal disbiosis in the development of mitochondrial dysfunction and nonalcoholic fatty liver disease
by: P. V. Seliverstov, et al.
Published: (2018-04-01)

Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
by: Heriberto Rodriguez-Hernandez, et al.
Published: (2010-04-01)

Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems
by: Ye-Na Kweon, et al.
Published: (2021-07-01)

Detection of patatin-like phospholipase domain-containing protein 3 in nonalcoholic fatty liver disease among egyptian patients
by: Kadry M El Saeed, et al.
Published: (2019-01-01)

A Model Construction of Starvation Induces Hepatic Steatosis and Transcriptome Analysis in Zebrafish Larvae
by: Hao Xu, et al.
Published: (2021-01-01)

Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity
by: Cacilda Pedrosa de Oliveira, et al.
Published: (2007-10-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

Dietary docosahexaenoic acid reverses nonalcoholic steatohepatitis and fibrosis caused by conjugated linoleic acid supplementation in mice
by: Yuriko Adkins, et al.
Published: (2016-01-01)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
by: Abo-Amer YEE, et al.
Published: (2020-03-01)

Predictive factors of metabolic changes after interferon-free treatment in hepatitis C infected patients
by: Ioana Hunea, et al.
Published: (2020-03-01)

The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids
by: Aline Gottlieb, et al.
Published: (2018-05-01)

Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients
by: Caroline Buss, R.D., Ph.D., et al.
Published: (2014-09-01)

The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy
by: Yini He, et al.
Published: (2020-01-01)

A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
by: Jonathan L. Temple, et al.
Published: (2016-06-01)

Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
by: Kasper W. ter Horst, et al.
Published: (2017-06-01)

Caractérisation de BMP9 (Bone Morphogenetic Protein 9), un nouveau biomarqueur de l'angiogenèse ?
by: Bidart, Marie
Published: (2012)

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
by: Kook Hwan Kim, et al.
Published: (2018-08-01)

Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
by: Jinyun Bai, et al.
Published: (2020-07-01)

Potential Roles of Bone Morphogenetic Protein (BMP)-9 in Human Liver Diseases
by: Blanca Herrera, et al.
Published: (2014-03-01)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Published: (2013-12-01)

Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single‐center observational study
by: Andrea Pasta, et al.
Published: (2021-10-01)

The Association between Vitamin D and Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter
by: Nam Ju Heo, et al.
Published: (2021-06-01)

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)
by: Ziwen Wang, et al.
Published: (2020-06-01)

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
by: Eric Hajduch, et al.
Published: (2021-02-01)

Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
by: Maria Guarino, et al.
Published: (2019-09-01)

Combined effects of lifestyle risk factors on fatty liver index
by: Ulla Nivukoski, et al.
Published: (2020-04-01)

Gallbladder Function and Hepatic Structural Changes in Children with Nonalcoholic Fatty Liver Disease
by: N.Yu. Zavgorodnya, et al.
Published: (2016-04-01)

Association Between Anxiety and Depression and Nonalcoholic Fatty Liver Disease
by: Ji Min Choi, et al.
Published: (2021-01-01)

The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study
by: Yeonjung Ha, et al.
Published: (2017-07-01)

Evolution of hepatic steatosis to fibrosis and adenoma formation in liver specific growth hormone receptor knockout (GHRLD) mice
by: Yong eFan, et al.
Published: (2014-12-01)

Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model
by: Melisa Kozaczek, et al.
Published: (2021-06-01)

Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease
by: Jingling Jin, et al.
Published: (2016-07-01)